[Association of polymorphic variants of PIP5K2A and HTR2C genes with response to antidepressant therapy of patients with a current depressive episode]. / Assotsiatsiia polimorfnykh variantov genov PIP5K2A i HTR2C s éffektivnost'iu antidepressivnoi terapii u patsientov s tekushchim depressivnym épizodom.

AIM: To study the association between polymorphisms of PIP5K2A and HTR2C genes and response to antidepressant therapy in patients with a current depressive episode. MATERIAL AND METHODS: The study included 222 patients (168 women and 54 men) with a current depressive episode. The assessment of the severity of the current depressive episode and the efficacy of treatment was performed using the Hamilton depression scale (HDRS-17) and the Clinical global impression scale (CGI-S, CGI-I). The association of treatment efficacy with PIP5K2A polymorphisms rs10430590, rs10828317 and HTR2C polymorphisms rs6318, rs569959, rs3813929, rs12858300 was studied. RESULTS AND CONCLUSION: Polymorphisms rs10828317 and rs10430590 in the PIP5K2A gene were associated with the CGI-S total score at day 28 of therapy. Polymorphism rs6318 in the HTR2C gene was associated with response to antidepressant therapy followed by clinical improvement of patients with current depressive episode on the 28th day of antidepressant therapy.

[Lysozyme in the feeding of premature infants with mixed pathology]. / Lizotsim v pitanii nedonoshennykh detei so smeshannoi patologiei.

Lysozyme is an important component of the breast milk. In the gastrointestinal tract of infants it performs the function of a local protective factor. The efficacy of the use of milk enriched with lysozyme was studied in feeding of 64 premature infants suffering from concomitant diseases. This clinical and laboratory study was performed as a part of the combined treatment and prophylactic measures. Lysozyme was added to the donor breast milk or to the dry adapted acidophilic mixture "Malyutka" in an amount of 50 mg per 1 liter of the final product. 29 infants were feeded with such milk products for 14-21 days of the observation period. The control group included 12 infants with artificial feeding and 23 infants feeded with the above milk products without addition of lysozyme. In spite of the significant differences in the initial state of the infants, a favourable effect of the feeding with addition of lysozyme was shown. It was comparable to the feeding with the breast milk. Improvement of the general state of the infants and the pathological processes in them, an increase in the body weight, more rapid sanation of the infectious inflammatory foci, normalization of the stool, stabilization of the lysozyme levels in the coprofiltrates and a tendency to normalization of the increased levels of lysozyme in the blood serum were observed. Satisfactory tolerance of the lysozyme enriched milk products was shown.